Iradimed earnings were $18.6M for the trailing 12 months ending Sep 30, 2024, with 14.7% growth year over year. The latest IRMD earnings report on Sep 30, 2024 announced Q3 2024 earnings of $5.0M, up 3% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, IRMD reported annual earnings of $17.2M, with 34% growth.
IRMD past earnings growth
How has IRMD's earnings growth performed historically?
On IRMD's earnings call on Invalid Date, Iradimed (NASDAQ: IRMD) reported Q3 2024 earnings per share (EPS) of $0.40, up 0% year over year. Total IRMD earnings for the quarter were $5.05 million. In the same quarter last year, Iradimed's earnings per share (EPS) was $0.40.
As of the last Iradimed earnings report, Iradimed is currently profitable. Iradimed's net profit (also called net income) for the twelve months ending Sep 30, 2024 was $18.63 million, a 14.09% increase year over year.
What was IRMD's earnings growth in the past year?
As of Iradimed's earnings date in Invalid Date, Iradimed's earnings has grown 14.73% year over year. This is 17.64 percentage points lower than the US Medical Devices industry earnings growth rate of 32.37%. IRMD earnings in the past year totalled $18.63 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.